These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7139671)

  • 41. [Post-transfusion hepatitis and the diagnosis of infectious hepatitis in donors (a review of the literature and the authors' own data)].
    Gromashevskaia LL; Khersonskaia RIa; Stroganov BV
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):40-5. PubMed ID: 4587776
    [No Abstract]   [Full Text] [Related]  

  • 42. Cost-effectiveness of introducing a third-generation test for HBsAg in Danish blood donors.
    Wantzin P; Skovgaard L; Tygstrup N; Nielsen JO; Soerensen H; Dybkjaer E
    Liver; 1986 Jun; 6(3):173-7. PubMed ID: 3091978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
    Weber B; Mühlbacher A; Melchior W
    J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The use of a test for anti-HBc for prevention of post-transfusion hepatitis B].
    Somova AV; Margolina AN; Golosova TV; Fisenko EP; Tsibinogin VV; Loseva VIa
    Vopr Virusol; 1989; 34(6):749-52. PubMed ID: 2633470
    [No Abstract]   [Full Text] [Related]  

  • 45. [Post-transfusion viral hepatitis].
    Katayama T
    Rinsho Byori; 1991 Mar; Suppl 88():156-70. PubMed ID: 1906949
    [No Abstract]   [Full Text] [Related]  

  • 46. [A study of potential risk of HBsAg negative with RPHA].
    Xiao YJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1991 May; 25(3):158-60. PubMed ID: 1914681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prevention of post-transfusion hepatitis. I. Evaluation of the effectiveness of donor selection by the test for HBsAg].
    Bondarenko MP; Stepanov GP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 May; (5):44-8. PubMed ID: 7269917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prevalence of hepatitis B surface antigen in the Gezira (Sudan).
    Elshafie SS
    Afr J Med Med Sci; 1992 Oct; 21(1):61-3. PubMed ID: 1288244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Letter: Rates of post-transfusion hepatitis.
    Allen JG
    N Engl J Med; 1975 May; 292(20):1078-9. PubMed ID: 1124092
    [No Abstract]   [Full Text] [Related]  

  • 50. Screening of HBsAg and post-transfusional hepatitis type B.
    Bedarida G; D'Agostino F; Lavezzi C; Tamagni F
    Boll Ist Sieroter Milan; 1978 May; 57(2):160-4. PubMed ID: 728267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg.
    Antar W; El-Shokry MH; Abd El Hamid WA; Helmy MF
    Transfus Med; 2010 Dec; 20(6):409-13. PubMed ID: 20573069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of hepatitis B after open heart surgery: a retrospective study over a three-year period (1974--1976).
    Stute R; Krian A; Staudacher B; Schulte HD; Brüster H
    Thorac Cardiovasc Surg; 1979 Aug; 27(4):238-40. PubMed ID: 494221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The importance of early and maternal antibodies to HBsAg in preventing hepatitis B in plasma recipients].
    Sychev AV; Mikhaĭlov MI; Shakhgil'dian IV
    Vopr Virusol; 1990; 35(3):197-9. PubMed ID: 2219850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis after the transfusion of frozen red cells and washed red cells.
    Haugen RK
    N Engl J Med; 1979 Aug; 301(8):393-5. PubMed ID: 460339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevention of transmission of infectious hepatitis by blood preparations through screening of GOT in blood donors].
    Novák J; Urbánková J
    Cas Lek Cesk; 1969 Jun; 108(24):734-7. PubMed ID: 5783179
    [No Abstract]   [Full Text] [Related]  

  • 56. [Serum hepatitis in donors and recipients].
    Khazanov AI; Stulov AP; Korolev SS; Ivlev AS; Verteletskiĭ VV
    Voen Med Zh; 1978 Dec; (12):41-3. PubMed ID: 734959
    [No Abstract]   [Full Text] [Related]  

  • 57. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Control of post-transfusion hepatitis by donor selection and case investigation.
    Taswell HF; Shorter R; Maxwell NG
    Mayo Clin Proc; 1972 Feb; 47(2):98-100. PubMed ID: 5010729
    [No Abstract]   [Full Text] [Related]  

  • 59. [Problems of prevention of post-transfusion type B hepatitis].
    Golosova TV
    Probl Gematol Pereliv Krovi; 1975 Apr; 20(4):9-16. PubMed ID: 1228774
    [No Abstract]   [Full Text] [Related]  

  • 60. The frequency and persistence of hepatitis-associated antigen in Calcutta blood donors and a case study of transfusion-associated hepatitis.
    Graves IL; Biswas SK
    Indian J Med Res; 1974 Mar; 62(3):384-93. PubMed ID: 4452587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.